Investigator-Initiated Clinical Trials in Neuroimmunology

Ben Raveney

National Institute of Neuroscience, NCNP, Japan

Department of Immunology National Institute of Neuroscience, NCNP Kodaira | Japan Ben Raveney completed his PhD in Cellular Immunology at the U [...]

Sonoko Misawa

Chiba University Graduate School of Medicine, Japan

Department of Neurology, Chiba University Graduate School of Medicine Chiba | Japan Dr. Sonoko Misawa is an Associate Professor at the Depar [...]

Tomoko Okamoto

National Center of Neurology and Psychiatry, Japan

Deputy Director of the Department of Neurology National Center Hospital, National Center of Neurology and Psychiatry Kodaira | Japan Tomoko O [...]

Wakiro Sato

National Center of Neurology and Psychiatry (NCNP), Japan

Chief of Section of research and development strategy Translational Medical Center National Center of Neurology and Psychiatry (NCNP) Kodaira | Jap [...]

16:05-16:25 | POEM Syndrome
Sonoko Misawa (Chiba University Graduate School of Medicine – Chiba, Japan)

16:25-16:45 | Potential novel therapeutic agent with unique mechanism of action for multiple sclerosis: OCH
Tomoko Okamoto (National Center of Neurology and Psychiatry – Kodaira, Japan)

16:45-17:05 | An exploratory, placebo-controlled, double-blind, phase II study to evaluate the efficacy and safety of rituximab in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Wakiro Sato (National Center of Neurology and Psychiatry (NCNP) – Kodaira, Japan)

17:05-17:20 | TBD
Ben Raveney (National Institute of Neuroscience, NCNP – Kodaira, Japan)

Event Timeslots (1)

Room 301
16:05 - 17:20
Symposium 12